Effect of human epididymis protein 4 gene silencing on the malignant phenotype in ovarian cancer

被引:17
作者
Zou Shu-li [1 ]
Chang Xiao-hong [1 ]
Ye Xue [1 ]
Cheng Hong-yan [1 ]
Cheng Ye-xia [1 ]
Tang Zhi-jian [1 ]
Zhang Zu-juan [1 ]
Gao Li [1 ]
Chen Xin-hua [1 ]
Cui Heng [1 ]
机构
[1] Peking Univ, Peoples Hosp, Gynecol Oncol Ctr, Beijing 100044, Peoples R China
基金
中国国家自然科学基金;
关键词
human epididymis protein 4; RNA interference; ovarian carcinoma; carcinogenesis; EXPRESSION PROFILES; EPITHELIAL-CELLS; HE-4; HYBRIDIZATION; CARCINOMAS; INHIBITOR; IDENTIFICATION; BIOMARKER; MARKERS; WFDC2;
D O I
10.3760/cma.j.issn.0366-6999.2011.19.032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Human epididymis secretory protein 4 (HE4) has been proved to be a promising novel biomarker for the detection of epithelial ovarian carcinomas. Compared with CA125, HE4 assay demonstrated an improved ability to discriminate between pelvic mass with malignant and benign disease. Though it is well known that HE4 is overexpressed in ovarian cancer, however, the role of HE4 in the carcinogenesis and progression of ovarian cancer remains unkown. Methods In this study, we explored the role of HE4 in the carcinogenesis and progression of ovarian cancer. We screened nine ovarian cancer cell lines for HE4 expression, and using RNA interference (RNAi), we silenced HE4 gene expression in CaoV3 and SKOV3.ip1 ovarian cancer cell lines. We assessed the effect of HE4 gene silencing on the transformed phenotype by examining the cell cycle, apoptosis, proliferation and transwell migration/invasion in vitro. Results HE4 gene silencing induces G0/G1 arrest and blocks the progression from the G1 to S phase in CaoV3 and SKOV3.ip1 cells. HE4 knockdown also inhibited cell proliferation, migration and invasion in SKOV3.ip1 cells in vitro. Conclusion HE4 may be involved in the regulation of the cell cycle and promote ovarian cancer migration and invasion. Chin Med J 2011;124(19):3133-3140
引用
收藏
页码:3133 / 3140
页数:8
相关论文
共 36 条
[1]   DEMONSTRATION OF SKIN-DERIVED ANTILEUKOPROTEINASE (SKALP) AND ITS TARGET ENZYME HUMAN-LEUKOCYTE ELASTASE IN SQUAMOUS-CELL CARCINOMA [J].
ALKEMADE, HAC ;
VANVLIJMENWILLEMS, IMJJ ;
VANHAELST, UJGM ;
VANDEKERKHOF, PCM ;
SCHALKWIJK, J .
JOURNAL OF PATHOLOGY, 1994, 174 (02) :121-129
[2]   The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms [J].
Bingle, L ;
Singleton, V ;
Bingle, CD .
ONCOGENE, 2002, 21 (17) :2768-2773
[3]   WFDC2 (HE4): A potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung [J].
Bingle, Lynne ;
Cross, Simon S. ;
High, Alec S. ;
Wallace, William A. ;
Rassl, Doris ;
Yuan, Guanglu ;
Hellstrom, Ingegerd ;
Campos, Michael A. ;
Bingle, Colin D. .
RESPIRATORY RESEARCH, 2006, 7 (1)
[4]   Bladder cancer outcome and subtype classification by gene expression [J].
Blaveri, E ;
Simko, JP ;
Korkola, JE ;
Brewer, JL ;
Baehner, F ;
Mehta, K ;
DeVries, S ;
Koppie, T ;
Pejavar, S ;
Carroll, P ;
Waldman, FM .
CLINICAL CANCER RESEARCH, 2005, 11 (11) :4044-4055
[5]   Proteins with whey-aicidic-protein motifs and cancer [J].
Bouchard, D ;
Morisset, D ;
Bourbonnais, Y ;
Tremblay, GM .
LANCET ONCOLOGY, 2006, 7 (02) :167-174
[6]   Cancer of the ovary [J].
Cannistra, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (24) :2519-2529
[7]   Identification of new genes associated with breast cancer progression by gene expression analysis of predefined sets of neoplastic tissues [J].
Cimino, Daniela ;
Fuso, Luca ;
Sfiligoi, Christian ;
Biglia, Nicoletta ;
Ponzone, Riccardo ;
Maggiorotto, Furio ;
Russo, Giandomenico ;
Cicatiello, Luigi ;
Weisz, Alessandro ;
Taverna, Daniela ;
Sismondi, Piero ;
De Bortoli, Michele .
INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (06) :1327-1338
[8]   Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? [J].
Colozza, M ;
Azambuja, E ;
Cardoso, F ;
Sotiriou, C ;
Larsimont, D ;
Piccart, MJ .
ANNALS OF ONCOLOGY, 2005, 16 (11) :1723-1739
[9]   Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C [J].
Dechow, TN ;
Pedranzini, L ;
Leitch, A ;
Leslie, K ;
Gerald, WL ;
Linkov, I ;
Bromberg, JF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (29) :10602-10607
[10]   Secretory leukocyte protease inhibitor in cancer development [J].
Devoogdt, N ;
Revets, H ;
Ghassabeh, GH ;
De Baetselier, P .
SIGNAL TRANSDUCTION AND COMMUNICATION IN CANCER CELLS, 2004, 1028 :380-389